| 1 |
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8):801-810.
|
| 2 |
Van Der Poll T, Van De Veerdonk FL, Scicluna BP, et al. The immunopathology of sepsis and potential therapeutic targets [J]. Nat Rev Immunol, 2017, 17(7):407-420.
|
| 3 |
Biswas SK, Chittezhath M, Shalova IN, et al. Macrophage polarization and plasticity in health and disease [J]. Immunol Res, 2012, 53(1-3):11-24.
|
| 4 |
Sica A, Erreni M, Allavena P, et al. Macrophage polarization in pathology [J]. Cell Mol Life Sci, 2015, 72(21):4111-4126.
|
| 5 |
Liu YC, Zou XB, Chai YF, et al. Macrophage polarization in inflammatory diseases [J]. Int J Biol Sci, 2014, 10(5):520-529.
|
| 6 |
Malyshev I, Malyshev Y. Current concept and update of the macrophage plasticity concept: intracellular mechanisms of reprogramming and M3 macrophage ″switch″ phenotype [J]. Biomed Res Int, 2015, 2015:341308.
|
| 7 |
Labonte AC, Tosello-Trampont AC, Hahn YS. The role of macrophage polarization in infectious and inflammatory diseases [J]. Mol Cells, 2014, 37(4):275-285.
|
| 8 |
Arora S, Dev K, Agarwal B, et al. Macrophages: Their role, activation and polarization in pulmonary diseases [J]. Immunobiology, 2017, 223(4-5):383-396.
|
| 9 |
Wilson HM. SOCS proteins in macrophage polarization and function [J]. Front Immunol, 2014, 5:357.
|
| 10 |
Croasdell A, Duffney PF, Kim N, et al. PPARgamma and the innate immune system mediate the resolution of inflammation [J]. PPAR Res, 2015, 2015:549691.
|
| 11 |
Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance [J]. Nature, 2007, 447(7148):1116-1120.
|
| 12 |
Szanto A, Balint BL, Nagy ZS, et al. STAT6 transcription factor is a facilitator of the nuclear receptor PPARgamma-regulated gene expression in macrophages and dendritic cells [J]. Immunity, 2010, 33(5):699-712.
|
| 13 |
Liao X, Sharma N, Kapadia F, et al. Kruppel-like factor 4 regulates macrophage polarization [J]. J Clin Invest, 2011, 121(7):2736-2749.
|
| 14 |
Zhou D, Huang C, Lin Z, et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways [J]. Cell Signal, 2014, 26(2):192-197.
|
| 15 |
Luyendyk JP, Schabbauer GA, Tencati M, et al. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages [J]. J Immunol, 2008, 180(6):4218-4226.
|
| 16 |
Arranz A, Doxaki C, Vergadi E, et al. Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization [J]. Proc Natl Acad Sci U S A, 2012, 109(24):9517-9522.
|
| 17 |
Krausgruber T, Blazek K, Smallie T, et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses [J]. Nat Immunol, 2011, 12(3):231-238.
|
| 18 |
Eguchi J, Kong X, Tenta M, et al. Interferon regulatory factor 4 regulates obesity-induced inflammation through regulation of adipose tissue macrophage polarization [J]. Diabetes, 2013, 62(10):3394-3403.
|
| 19 |
Takeuch O, Akira S. Epigenetic control of macrophage polarization [J]. Eur J Immunol, 2011, 41(9):2490-2493.
|
| 20 |
Ishii M, Wen H, Corsa CA, et al. Epigenetic regulation of the alternatively activated macrophage phenotype [J]. Blood, 2009, 114(15):3244-3254.
|
| 21 |
Satoh T, Takeuchi O, Vandenbon A, et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection [J]. Nat Immunol, 2010, 11(10):936-944.
|
| 22 |
Essandoh K, Li Y, Huo J, et al. MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response [J]. Shock, 2016, 46(2):122-131.
|
| 23 |
Ying H, Kang Y, Zhang H, et al. MiR-127 modulates macrophage polarization and promotes lung inflammation and injury by activating the JNK pathway [J]. J Immunol, 2015, 194(3):1239-1251.
|
| 24 |
Banerjee S, Xie N, Cui H, et al. MicroRNA let-7c regulates macrophage polarization [J]. J Immunol, 2013, 190(12):6542-6549.
|
| 25 |
Porta C, Rimoldi M, Raes G, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB [J]. Proc Natl Acad Sci U S A, 2009, 106(35):14978-14983.
|
| 26 |
Pena OM, Pistolic J, Raj D, et al. Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells [J]. J Immunol, 2011, 186(12):7243-7254.
|
| 27 |
Xu G, Feng L, Song P, et al. Isomeranzin suppresses inflammation by inhibiting M1 macrophage polarization through the NF-kappaB and ERK pathway [J]. Int Immunopharmacol, 2016, 38:175-185.
|
| 28 |
Shu B, Feng Y, Gui Y, et al. Blockade of CD38 diminishes lipopolysaccharide-induced macrophage classical activation and acute kidney injury involving NF-kappaB signaling suppression [J]. Cell Signal, 2018, 42:249-258.
|
| 29 |
Singh P, Dejager L, Amand M, et al. DUSP3 genetic deletion confers M2-like macrophage-dependent tolerance to septic shock [J]. J Immunol, 2015, 194(10):4951-4962.
|
| 30 |
Tang H, Liang YB, Chen ZB, et al. Soluble egg antigen activates M2 macrophages via the STAT6 and PI3K pathways, and schistosoma japonicum alternatively activates macrophage polarization to improve the survival rate of septic mice [J]. J Cell Biochem, 2017, 118(12):4230-4239.
|
| 31 |
Song Y, Dou H, Li X, et al. Exosomal miR-146a contributes to the enhanced therapeutic efficacy of interleukin-1beta-primed mesenchymal stem cells against sepsis [J]. Stem Cells, 2017, 35(5):1208-1221.
|
| 32 |
Xia H, Chen L, Liu H, et al. Protectin DX increases survival in a mouse model of sepsis by ameliorating inflammation and modulating macrophage phenotype [J]. Sci Rep, 2017, 7(1):99.
|
| 33 |
Li X, Mu G, Song C, et al. Role of M2 macrophages in sepsis-induced acute kidney injury [J]. Shock, 2018, 50(2):233-239.
|
| 34 |
Venet F, Rimmele T, Monneret G. Management of sepsis-induced immunosuppression [J]. Crit Care Clin, 2018, 34(1):97-106.
|